Umeclidinium + Vilanterol
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Umeclidinium
umeclidinium - Vilanterol
vilanterol
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| umeclidinio + vilanterolES | 0.055 mg / 0.022 mg | Glaxosmithkline (Ireland) Limited |
| Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhalerGB | — | Ennogen Healthcare Ltd |
| Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhalerGB | — | GlaxoSmithKline UK Ltd |
| Anoro Ellipta 62.5/25AU | 0.0625 mg / 0.025 mg | GlaxoSmithKline Australia Pty Ltd |
| umeclidinium + vilanterolAU | 0.0625 mg / 0.025 mg | GlaxoSmithKline Australia Pty Ltd |
| ANORO ELLIPTA INHALATION POWDER PRE-DISPENSED 62.5MCG/25MCGHK | — | GLAXOSMITHKLINE LIMITED |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- ES · ANORO ELLIPTA; LAVENTAIR ELLIPTA · 7 products · record
- GB · Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler · 4 products · record
- AU · Anoro Ellipta 62.5/25 · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.